Patents by Inventor Ken Aoshima

Ken Aoshima has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9581604
    Abstract: Desmosterol alone, the combination of desmosterol and amyloid beta, the combination of desmosterol and gelsolin and the combination of desmosterol, amyloid beta and gelsolin can be used as in-blood biomarkers for Alzheimer's disease or mild cognitive impairment. A method for evaluating the effect of a candidate for a therapeutic agent to treat Alzheimer's disease or mild cognitive impairment, a method for aiding the diagnosis of Alzheimer's disease or mild cognitive impairment, and a method for diagnosing Alzheimer's disease or mild cognitive impairment are provided in which the biomarkers are used.
    Type: Grant
    Filed: June 23, 2011
    Date of Patent: February 28, 2017
    Assignee: Eisai R&D Management Co., Ltd.
    Inventors: Yoshiaki Sato, Ken Aoshima, Francois Bernier
  • Publication number: 20130266589
    Abstract: Desmosterol alone, the combination of desmosterol and amyloid beta, the combination of desmosterol and gelsolin and the combination of desmosterol, amyloid beta and gelsolin can be used as in-blood biomarkers for Alzheimer's disease or mild cognitive impairment. A method for evaluating the effect of a candidate for a therapeutic agent to treat Alzheimer's disease or mild cognitive impairment, a method for aiding the diagnosis of Alzheimer's disease or mild cognitive impairment, and a method for diagnosing Alzheimer's disease or mild cognitive impairment are provided in which the biomarkers are used.
    Type: Application
    Filed: June 23, 2011
    Publication date: October 10, 2013
    Applicant: EISAI R&D MANAGEMENT CO., LTD.
    Inventors: Yoshiaki Sato, Ken Aoshima, Francois Bernier